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Abstract
Background: Pulmonary function measurements are important when studying respiratory disease models. Both
resistance and compliance have been used to assess lung function in mice. Yet, it is not always clear how these
parameters relate to forced expiration (FE)-related parameters, most commonly used in humans. We aimed to
characterize FE measurements in four well-established mouse models of lung diseases.
Method: Detailed respiratory mechanics and FE measurements were assessed concurrently in Balb/c mice, using
the forced oscillation and negative pressure-driven forced expiration techniques, respectively. Measurements were
performed at baseline and following increasing methacholine challenges in control Balb/c mice as well as in four
disease models: bleomycin-induced fibrosis, elastase-induced emphysema, LPS-induced acute lung injury and house
dust mite-induced asthma.
Results: Respiratory mechanics parameters (airway resistance, tissue damping and tissue elastance) confirmed
disease-specific phenotypes either at baseline or following methacholine challenge. Similarly, lung function defects
could be detected in each disease model by at least one FE-related parameter (FEV0.1, FEF0.1, FVC, FEV0.1/FVC ratio
and PEF) at baseline or during the methacholine provocation assay.
Conclusions: FE-derived outcomes in four mouse disease models behaved similarly to changes found in human
spirometry. Routine combined lung function assessments could increase the translational utility of mouse models.
Keywords: Fibrosis, Emphysema, Asthma, Acute lung injury, Mice, Forced oscillations technique, Negative pressure
forced expiration, Airway resistance, Tissue elastance, Forced expiratory volume, Forced vital capacity
Background
At the preclinical level in experimental animals, pulmonary
function is generally assessed using the forced oscillation
technique (FOT). This is an invasive method allowing
accurate measurements of physiologically relevant parame-
ters describing the mechanical properties of the respiratory
system. The classical parameters of respiratory mechanics,
resistance and compliance, relate to the opposition to air
moving in and out of the lungs and to the distensibility of
the respiratory system, respectively. These measurements
are based on the analysis of pressure, volume, and flow
signals acquired in response to oscillatory airflow
waveforms applied at the subject’s airway opening [1].
Through the use of complex oscillatory signals and
advanced mathematical model fitting, this technique
is also able to distinguish between airway and tissue
mechanics [2].
FOT measurements have already been used in mouse
models of respiratory diseases to investigate patho-
physiological changes associated with fibrosis [3], em-
physema [4], or asthma [5–8]. Yet, from a pre-clinical
perspective, the translational value of the mouse as a
model to study respiratory diseases has been challenged
and it is not always clear how changes in respiratory me-
chanics parameters relate to the commonly measured
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forced expiration (FE) parameters in humans [9].
Nowadays, spirometric-like measures can be performed
in mice by rapidly exposing the airways to a negative
pressure in order to generate a forced expiratory flow
signal [10]. The technique is referred to as negative
pressure-driven forced expiration (NPFE) and it can be
performed concurrently with FOT measurements, in
the same animal using a single device, to obtain, in
addition to respiratory mechanics’ parameters,
endpoints resembling the clinically used ones, such as
forced expiratory volume at 0.1 s (FEV0.1), forced vital
capactity (FVC), “Tiffeneau” index (FEV0.1/FVC) or
peak expiratory flow (PEF). As is the case for human
subjects, both FOT and FE outcomes can also be
measured during a bronchoprovocation test to
increasing concentrations of methacholine to deter-
mine airway hyperresponsiveness (AHR) [9, 10].
Previously, Vanoirbeek et al. [11] reported flow-
volume (FV) loops and associated FE parameters
measured at baseline in mouse models of asthma, fi-
brosis and emphysema. In that particular study, FE
measurements were performed with a system
deprived of any aerosol generation or FOT measure-
ment capabilities. Therefore, in order to be able to
assess airway responsiveness to aerosolized metha-
choline, the subjects had to be moved from the FOT
device to the FE system during the course of the
experiment. In addition to the technical challenges
and a loss in precision in the timing of the measure-
ments, the use of that FE system was also associated
with the need to manually construct the FV curves,
which were generated from a total of 9 data points
acquired during the FE maneuver. More recent FE
systems now have the ability to automatically
generate FV loops and derive FE parameters. In
addition, the FV curves are constructed from higher
resolution volume and flow signals (containing
approximately 360 data points), thus providing a
more accurate and specific assessment of the respira-
tory system under conditions of greater expiratory
pressure gradient. The objective of this study was to
evaluate FE endpoints (FEV0.1, FVC, PEF, FEV0.1/
FVC) as potential diagnostic parameters in different
mouse models of respiratory diseases. In order to do
so, we seamlessly performed FOT and NPFE mea-
surements at baseline and after increasing concentra-
tions of methacholine using a single measurement
device that provided an accurate FE assessment.
Since the hypothesis was that FE-related changes
would generally behave similarly to changes found in
human spirometry across a range of respiratory
diseases, we included a model of lung fibrosis,
emphysema, and acute lung injury, as well as a
model of allergic asthma. All four mouse respiratory
disease models were compared to a group of naive
control animals.
Methods
Reagents
Acetyl-β-methylcholine (methacholine, MCh), cyclophos-
phamide monohydrate, porcine pancreatic elastase (PPE)
and lipopolysaccharide (LPS) were supplied from Sig-
ma-Aldrich (Bornem, Belgium). Formaldehyde (36%) was
obtained from VWR international (Leuven, Belgium) and
was diluted to 4% in distilled water. Bleomycin sulfate
(Bleo) was supplied from Sanofi-Aventis (Diegem,
Belgium), Isoflurane (Forene) from Abbott (Ottignies,
Belgium), Pentobarbital sodium (Nembutal) from Sanofi
Santé animale (CEVA, Brussels, Belgium), Xylazine from
VMD S.A. (Arendonk, Belgium) and Ketamine from
Eurovet Animal Health (Bladel, Netherlands).
Animals and disease models
Male BALB/c mice, obtained from Harlan (The
Netherlands) at 9 weeks old, were divided into 5 different
groups: bleomycin (Bleo)-induced lung fibrosis (n = 10),
porcine pancreatic elastase (PPE)-induced emphysema
(n = 10), lipopolysaccharide (LPS)-induced acute lung
injury (ALI) (n = 8), house dust mite (HDM)-induced
allergic asthma (n = 7), and an untreated control
group (n = 8). Due to expected mortality in the Bleo
fibrosis and the PPE emphysema groups, we included
two extra mice in each one. All mice were housed in
a conventional animal facility with 12-h dark/light
cycles. They were housed in filter top cages and
received lightly acidified water and pelleted food ad
libitum. All experimental procedures performed in
mice were approved by the KU Leuven local Ethical
Committee for animal experiments (P166-2012).
Fibrosis
To induce pulmonary fibrosis, mice (10 weeks old) received
an intraperitoneal injection of cyclophosphamide
(100 mg/kg). Two days later, the animals were anes-
thetized with an intraperitoneal injection of ketamine/
xylazine (100 mg/kg ketamine and 10 mg/kg xylazine;
100 μL/10 g) and intratracheally instilled with bleomycin.
Bleomycin was dissolved in sterile PBS and administered as
a single dose of 0.1 unit/40 μL per animal [11–13]. At the
age of 14 weeks, i.e. three weeks after the first bleomycin
administration, mice were evaluated (see Additional file 1:
Figure S1).
Emphysema
Emphysema was induced in mice (9 weeks old) by adminis-
tration of porcine pancreatic elastase (PPE). PPE was dis-
solved in sterile saline and administered in a dose of 1.5
units/50 μL per animal by intranasal instillation, after light
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anesthesia with isoflurane. Mice were subsequently exposed
on a weekly basis to 1.5 units PPE via the same administra-
tion route during a period of three weeks [11, 12, 14]. At
the age of 14 weeks, i.e. three weeks after the last PPE
instillation, mice were evaluated (see Additional file 1:
Figure S1).
Acute lung injury
To induce acute lung injury, mice (13 weeks old), re-
ceived a single intranasal instillation of LPS. LPS was
dissolved in sterile saline and administered as a single
dose of 3 μg/40 μL/mouse after light anesthesia [15].
The mice were studied at the age of 13 weeks, i.e.
two days after the instillation (see Additional file 1:
Figure S1).
Allergic asthma
BALB/c mice (11 weeks old) were endonasally sensitized
with 1 μg of HDM extract (Greer Laboratories, Lenoir,
NC) in 50 μL of saline at day 1. At days 8 to 13, mice
were endonasally challenged with 10 μg of HDM extract
in 50 μL of saline [16]. Two days after the last challenge,
i.e. at the age of 13 weeks, lung function measurements
were performed (see Additional file 1: Figure S1).
Lung function measurements
FOT and FE measurements were performed using the
flexiVent FX system (SCIREQ Inc., Montreal Qc,
Canada). The system was equipped with a FX1 module
as well as with a NPFE extension for mice and it was
operated by the flexiWare v7.2 software. A small particle
size Aeroneb Lab nebulizer (2.5–4 μm; Aerogen, Galway,
Ireland) was integrated in the inspiratory arm of the
Y-tubing for the generation of the aerosol challenges.
The nebulizer activation was synchronized with inspir-
ation and set to a 50% duty cycle for 5 s. On the day of
the experiment, mice were anesthetized with an IP
injection of pentobarbital sodium (70 mg/kg body
weight). Once a surgical plane of anaesthesia was
reached, the trachea was exposed to insert an 18-gauge
metal cannula having a typical resistance of 0.3
cmH2O.s/mL. Mice were quasi-sinusoidally ventilated
with a tidal volume of 10 mL/kg, a frequency of 150
breaths/min, an inspiratory to expiratory ratio of 2:3,
and a positive end-expiratory pressure of 3 cmH2O.
A. Baseline measurements
At the start of an experiment, two deep inflations were
successively applied to maximally inflate the lungs to a
pressure of 30 cmH2O in order to open-up closed areas
and standardize lung volume. The lungs were allowed to
equilibrate at that pressure over a period of 3 s and the
gas compression-corrected volume was read as the
subject’s inspiratory capacity (IC), typically on the
second maneuver. A broadband forced oscillation wave-
form inducing frequencies between 0.5 to 19.75 Hz
(Prime-8; P8) was then applied to the subject’s airway
opening during 8 s. This FOT measurement was analyzed
by fitting the constant-phase model to the respiratory input
impedance calculated from the P8 experimental data [2].
This mathematical model allows the separate assessment of
the airway and tissue contributions to the respiratory
response. The Newtonian resistance (Rn, airway resistance,
which is dominated by the resistance of the large
conducting airways), tissue damping (G, closely associated
to tissue resistance and the resistance of the small periph-
eral airways), tissue elastance (H), and tissue hysteresivity
(eta) (G/H) were considered in this study, provided that the
coefficient of determination of the model fit was ≥ 0.9. This
was followed by the construction of a pressure-volume
(PV) curve using a ramp-style pressure-driven maneuver
(PVr-P), from which the static compliance (Cst) was calcu-
lated directly from the deflating arm of the PV loop
between the pressures of 3 –7 cmH2O. Considering the
high distensibility of emphysematous lungs, PV loops of
mice with emphysema were only reported if the maximum
inflation pressure of +30 cmH2O was reached. The hyster-
esis (Area), or area between inflation and deflation limb of
the PV curve, was also calculated. Finally, a NPFE maneu-
ver was performed to obtain a FV loop and the FE-related
parameters. This was done by first inflating the lungs to a
pressure of +30 cmH2O over 1.2 s and then rapidly expos-
ing the subject’s airways to a negative pressure of -55
cmH2O to generate an imposed negative expiratory pres-
sure gradient. From the FE parameters, the forced expira-
tory volume and flow at 0.1 s (FEV0.1, FEF0.1, respectively),
forced vital capacity (FVC), and peak expiratory flows (PEF)
were considered in the present study as well as the FEV0.1/
FVC (referred to as Tiffeneau index in humans at 1 s).
B. Airway responsiveness assessment
After performing the sequence of measurements at base-
line level, a protocol for measuring airway responsive-
ness (AHR) to methacholine (MCh) was initiated. Each
mouse was exposed for 5 s to an aerosol of a solution of
MCh in increasing concentrations (0, 1.25, 2.5, 5, 10,
20 mg/mL). Starting almost immediately after the end of
the aerosol exposure, an automated sequence of closely-
spaced FOT measurements was initiated using the 3 s
long, broadband forced oscillation perturbation ‘Quick
Prime-3’ (QP3). Five consecutive QP3 perturbations
were run at approximately 15 s apart, resulting in 5 mea-
surements for each concentration of MCh. Each
sequence was followed by a NPFE measurement taken
approximately 15 s after the last FOT measurement. The
dose-response curve to MCh was constructed in a
cumulative manner with no recruitment maneuvers in
between aerosol challenges as this approach had the
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advantage of enabling the separation between control
and disease mice. Since the NPFE-induced derecruit-
ment of lung units was not reversed by a deep lung in-
flation maneuver in between aerosol challenges and that
it was shown to specifically affect the tissue-related pa-
rameters G and H [10], Rn was the only FOT-related
parameter considered in assessing airway responsiveness
to MCh in the present study to avoid any confounding
effects.
For each mouse of the LPS-ALI, HDM-asthma and
control group, the provocative concentration of MCh
inducing either a 20 (PC20), 30 (PC30) or 40% (PC40)
decrease in FEV0.1 was assessed, by calculating the slope
of the dose-response curve of each individual mouse,
where the peak responses to MCh were normalized to
the FEV0.1 of 0 mg/ml MCh (=100%).
Inflammatory cells in the bronchoalveolar lavage fluid
Immediately after the lung function measurements, the
lungs were lavaged, in situ, three times with 0.7 mL sterile
saline (0.9% NaCl), and the recovered fluid was pooled.
Cells were counted using a Bürker hemocytometer (total
cells) and the bronchoalveolar lavage (BAL) fluid was centri-
fuged (1000 g, 10 min). For differential cell counts, 250 μL
of the resuspended cells (100,000 cells/mL) were spun
(1400 g, 6 min) (Cytospin 3, Shandon, TechGen, Zellik,
Belgium) onto microscope slides, air dried and stained
(Diff-Quik® method, Medical Diagnostics, Düdingen,
Germany). For each sample, 200 cells were counted for the
number of macrophages, eosinophils, neutrophils and
lymphocytes.
Histopathology
The lungs were fixated in 4% of formaldehyde. After
dehydration and embedding in paraffin, sagittal sections
were stained with hematoxylin and eosin (H&E).
Statistical analyses
For each mouse, the average of all measurements was
calculated for Rn, grouped per experimental conditions,
and plotted against MCh concentration. The results are
presented as mean ± standard deviation. MCh dose-
response curves (Rn, FEV0.1, and FVC) were analyzed
using a two-way parametric analysis of variance (ANOVA)
followed by a Bonferroni multiple comparison post hoc
test to compare each treatment group with the control
group. The area under the MCh dose-response curve
(AUC) was also calculated and statistically analyzed using
a one-way parametric ANOVA. All other statistical
analyses were performed using unpaired t-tests, to
compare each disease entity separately with the control
group (GraphPad prism 5.01, Graphpad Software Inc., San
Diego, CA).
Results
During the induction protocols, two mice of the PPE--
treated (emphysema) group and two mouse of the Bleo-
treated (fibrosis) group died. In both groups, mice had sig-
nificantly lower body weights on the day of analysis, com-
pared with the control group. In the HDM asthma group,
one mouse was excluded because all data were far out of
the 95th percentile of the group. All data reflect measure-
ments from at least seven mice per group.
Inflammatory cells in BAL fluid
Compared to the control group, significantly higher
numbers of neutrophils were found in the BAL-fluid of
mice with bleomycin-induced fibrosis and LPS-induced
acute lung injury (ALI). Similarly, significantly higher
numbers of eosinophils were found in mice with
HDM-induced asthma, in comparison to naive control
mice. Lymphocytes were significantly increased in mice
with bleomycin-induced fibrosis, elastase-induced
emphysema and HDM-induced asthma, compared to
naive controls (Fig. 1a).
Histopathology
To further confirm the underlying pathology, paraffin
sections of the lungs were obtained of every mouse.
Figure 1 shows an illustrative example of each group.
Compared to naive control mice (Fig. 1b), mice with
fibrosis presented with a heterogeneous inflammatory
cell infiltrate in both the broncho-vascular bundle and
alveolar parenchyma, and fibrous thickening of alveolar
septa (Fig. 1c), whereas mice with emphysema presented
with a typical heterogeneous destruction of the pulmon-
ary parenchyma (Fig. 1d). Mice with ALI showed a mild
infiltration of inflammatory cells, including mononuclear
cells and granulocytes in the broncho-vascular bundle
and intra-alveolar (Fig. 1e). Mice with asthma showed a
pronounced infiltration of mononuclear cells and granu-
locytes in the broncho-alveolar bundle and in the venous
vascular tree. Mild intra-alveolar inflammation was also
present (Fig. 1f ).
Lung function measurements
A. Baseline measurements
A complete overview of all parameters measured at base-
line is reported in the Additional file 2.
FOT respiratory mechanics measurements Consistent
with an anticipated increase in tissue stiffness and elastic
recoil, mice treated with bleomycin displayed, at baseline,
elevated values of G (tissue damping) and H (tissue elas-
tance) relative to naive control mice, with no statistical
difference in Rn (central airway resistance) (Fig. 2). In con-
trast, in the PPE-treated mice, where a decrease in elastic
recoil was expected, G and H were significantly decreased
Devos et al. Respiratory Research  (2017) 18:123 Page 4 of 14
compared to control animals, resulting in a significantly
increased tissue hysteresivity (G/H). These animals also
showed a significant increase in airway resistance (Rn) in
comparison to the control group (Fig. 2a). As seen in
Fig. 1, mice with ALI also presented with an increase in
Rn, compared to the naive healthy mice. Baseline parame-
ters of mice with HDM-induced asthma did not differ
from those of naive control mice (Fig. 2).
Pressure-volume loop and inspiratory capacity The
PV loop of mice with fibrosis showed a characteristic
downward shift, while those of emphysematous mice
displayed a typical upward shift, compared to naive
control mice (Fig. 3a). Consistent with an increased
stiffness of the lungs, mice with fibrosis showed a sig-
nificant decrease in IC and Cst compared to naive
controls (Fig. 3c, d). Emphysematous mice, on the
other hand, showed a statistically elevated IC with,
however, no significant change in Cst relative to the
control mice (Fig. 3c). The PV loops from the mice
with ALI or with asthma appeared very similar to
those from the naive control ones (Fig. 3b). Consist-
ently, IC and Cst were unchanged across these
experimental groups (Fig. 3c and d).
FE measurements Forced expiration in mice with fibro-
sis resulted in a characteristic FV loop compared to con-
trol mice, with reduced PEF and FVC suggestive of
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50× and 200×, shown for naive control group (b), Bleo-fibrosis (c), PPE-emphysema (d), LPS-ALI (e) and HDM-asthma (f). Data are
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restrictive lung disease (Fig. 4a). FV curves of emphyse-
matous mice also displayed a pronounced decrease in
PEF with, however, an increased FVC relative to control
healthy mice (Fig. 4a). The FV curves of mice with ALI
and asthma generally followed the curve of control mice,
with some reductions in PEF (Fig. 4b).
These changes in the shape of the FV loops were
also reflected in the FE-derived parameters (Fig. 5).
Consistent with a typical restrictive airway pattern
seen in human patients, mice with fibrosis showed at
baseline a significantly reduced FEV0.1, FVC and PEF,
as well as a normal FEV0.1/FVC ratio (Fig. 5). In
mice with emphysema FVC and FEF0.1 were signifi-
cantly increased, while FEV0.1, PEF and FEV0.1/FVC
ratio were significantly decreased. From all FE-
related parameters, PEF was significantly decreased
in mice with ALI, compared to naive controls.
HDM-induced asthma mice displayed at baseline FE-
derived parameters that generally followed what was
seen in the control mice, with the exception of a
small but statistically significant increase in FVC.
B. Assessment of airway responsiveness to methacholine
In this B section, we report MCh responses exclusively for
mice with LPS-induced ALI and HDM-induced asthma,
as these provide clinically-relevant information.
FOT respiratory mechanics measurements AHR,
expressed in terms of central airway resistance (Rn), was
absent in mice with ALI (Fig. 6a), but present, as
expected, in mice with asthma (Fig. 6b). In this latter
group, Rn was significantly increased at the two highest
concentrations of MCh tested, compared to naive
control mice (Fig. 6b).
FE measurements Mice with ALI displayed a similar
FV loop shape profile as the control ones in response
to increasing MCh aerosol challenges (Fig. 7a,b). The
shape of the FV loops of the mice with HDM-
induced asthma became more concave with increasing
concentrations of MCh, reflecting a typical pattern of
airflow limitation due to obstruction. The FV curve of
the HDM-treated group also showed a decreasing
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trend in PEF and in FVC relative to control mice
with increasing concentrations of MCh (Fig. 7a,c).
As for the associated NPFE-related parameters, all
groups showed a decreasing trend in FEV0.1 and/or
FVC with increasing concentrations of MCh (Fig. 8).
In mice with ALI, FEV0.1 was significantly reduced at
0, 0.6, 1.25 and 5 mg/mL of MCh, compared to con-
trol mice (Fig. 8a) although the differences between
the two groups were small. Also, FVC was signifi-
cantly reduced over a similar range of MCh concen-
trations (Fig. 8b). The FEV0.1/FVC ratio of mice with
ALI did not differ from naive controls (see Additional
file 3: Figure S2). In mice with HDM-induced asthma,
both FEV0.1 and FVC were significantly lower at all
MCh concentrations compared to control mice
(Fig. 8). The curves of FEV0.1/FVC ratio of mice
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treated with HDM, followed the curve of control
mice (see Additional file 3: Figure S2).
The provocative concentration of MCh required to in-
duce a 20, 30 or 40% decrease in baseline FEV0.1, was
significantly lower in mice with HDM-induced asthma
compared to naive controls (Fig. 9). In mice with ALI,
no changes in provocative concentrations of MCh were
found, compared to naive controls (data not shown).
Discussion
The lung carries many functions within the body, the most
important being that of providing a constant supply of O2 /
removal of CO2 through the process of respiration. This
function of the lung is essentially a mechanical one, as it re-
lies on changes in pressure and volume. While it is highly
influenced by the mechanical properties of the respiratory
system, the lung can very often continue to carry it out
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under tidal volume conditions despite significant histologic
disease manifestations. Therefore, it is frequently necessary
to study the lung under different conditions in order to de-
tect pathological lung function defects. In the present study,
we performed FE measurements in four well-established
mouse models of respiratory diseases with the objective of
further assessing disease-specific changes using FE-derived
parameters. Studying the lung under forced expiration as-
sesses its function under conditions susceptible of inducing
expiratory flow limitation. Combined with measurements
of respiratory mechanics, specific lung volumes, and quasi-
static pressure-volume curves, FE measurements can
potentially add valuable information and contribute to
produce a more comprehensive functional assessment. This
approach, which explores the linear as well as the non-
linear behaviors of the lung, might be particularly import-
ant in mouse models, given the relatively large airways that
mice have for their body size [17, 18].
In the present study, all these measurements were
performed at baseline as well as in response to MCh
provocations, in order to study the lungs under a
greater level of functional impairment. The measure-
ment device used offered a refined study design in
the sense that all measurement types could be made
seamlessly in the same subject, with no need to move
it during the course of the experimental protocol or
other inconveniences associated to the use of separate
pieces of equipment [11]. In addition, the raw signals
generated during the forced expiration maneuver were
of improved quality relative to previously published
work [11].
FOT measurements at baseline proved to be useful to
assess lung function in models of pulmonary fibrosis
[13] and pulmonary emphysema [12, 14] and confirm
the expected changes in respiratory mechanics. The re-
strictive pathology, observed in mice with fibrosis, was
also reflected in FE-related parameters. FEV0.1, FVC and
PEF were significantly decreased in mice with fibrosis,
and could, thus, serve as diagnostic parameters having
some similarities with those routinely used in the clinic.
This is in contrast to the earlier study of Vanoirbeek et al.,
where less changes in FE-related variables could be
observed in mice with fibrosis [11]. In line with the current
study, Tanaka et al. reported an increase in respiratory elas-
tance and tissue elastance, as well as a decrease in FVC in
mice with bleomycin-induced pulmonary fibrosis [19].
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Fig. 8 FE-derived parameters. Negative pressure-driven forced expiration maneuvers were performed at baseline and following each methacholine
aerosol challenge (0 –20 mg/mL). Forced expiratory volume at 0.1 s, FEV0.1 (a, c), forced vital capacity, FVC (b, d) are shown for LPS-ALI (a, b) and HDM-
asthma (c, d). The mean (± SD) concentration-response curve of each group is represented together with that of the naive control group. * p < 0.05, **
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Characterization of the pathology of pulmonary em-
physema in mice treated with PPE showed the expected
decrease in G and H, and an upward shift in the PV
loop, reflecting decreased elastic recoil. Consistently,
there was an increase in the inspiratory capacity and a
decrease in PEF, but no significant change in Cst in
our model, compared to naive healthy mice. Further-
more, in contrast to the human disease situation,
FVC was increased, resulting in a decreased FEV0.1/
FVC ratio [20, 21]. These results correspond with
those of Tanaka et al., who also assessed lung
mechanics and respiratory dysfuntion in mice with
PPE-induced pulmonary emphysema, in terms of
tissue elastance and FEV0.05, using FOT and NPFE
techniques, respectively [22]. Similar to our results,
they detected a pronounced decrease in both tissue
elastance and FEV0.05 under baseline conditions. The
lack of change in Cst observed in our study could be
related to the model used, the style of the PV loop
used (ramp versus plateau style), or alternatively, to
the fact that the PV loop was constructed over the
inspiratory capacity range instead of over the full lung
volume range [23].
The FE-derived parameters discussed in this study,
although similar to those reported in humans, were
generated by negative pressure. This methodology differs
from the technique used with patients and could
possibly be responsible for some of the discrepancies
observed. In the PPE-treated mice, FEF0.1 was signifi-
cantly increased compared to control mice and therefore
differs from what is typically observed in human subjects
[20, 21]. Airway collapse and expiratory flow limitation
are important factors influencing forced expired flow
and these are sensitive to changes in the mechanical
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properties of the respiratory system. As shown by a signifi-
cant decrease in H, PPE-treated mice displayed an
increased lung compliance which, under negative
pressure-driven forced expiration, most likely led to the
creation of a choke point at a higher location in the airway
tree than in the control mice, thus resulting in a higher
upstream airway calibre and therefore a higher expiratory
flow at the selected time and negative pressure.
We also included a model of acute lung injury (ALI),
induced by endotoxin (LPS) exposure and characterized
by acute neutrophilic inflammation. FEV0.1 remained
unchanged in this mouse model. However, a significant
increase in Rn was observed in the LPS-ALI mice com-
pared to control ones, as well as a significant decrease in
PEF, demonstrating the value of these measurements.
As shown before [11], mouse models of airway inflamma-
tion and airway hyperresponsiveness often display normal
values for respiratory mechanics parameters measured
under baseline conditions. Similarly, Rn and H were not af-
fected in mice with HDM-induced asthma. Also in parallel
to the study of Vanoirbeek et al. [11], Cst and IC did not
differ from naive controls under baseline conditions.
As expected, enhanced MCh airway responsiveness
relative to control mice could be demonstrated in mice
treated with HDM (i.e. increased central airway resist-
ance, Rn). In mice with ALI, the absence of MCh hyper-
responsiveness in terms of Rn is in line with the findings
of Secher et al. [24] in male C57BL/6 mice. However,
this latter study contradicts the work of Card et al. [25],
in which it was reported that LPS-treated male C57BL/6
mice, and not female, exhibit an exaggerated MCh-
evoked airway response. There are some small technical
differences that distinguish these studies, however, the
lack of AHR in the present model of neutrophilic in-
flammation further confirms the existence of a dissoci-
ation between recruitment of inflammatory cells and the
development of AHR [26–28].
In this study, we also measured airway responsiveness
to MCh in terms of FE-derived variables. In contrast to
the study of Shalaby et al. [10], we did not perform a
deep inflation after each FE measurement to reverse the
derecruitment of lung units caused by the NPFE maneuver
in order to be able to measure airway responsiveness in the
HDM-asthma model over a low methacholine concentra-
tion range. Mucus is often present in the airways of allergi-
cally inflamed mice and methacholine is a known mucus
secretagogue [29]. That technical difference most likely
enabled us to reach a greater level of airway functional
impairment at any given challenges by limiting the subse-
quent amount of aerosol delivered to the peripheral airways
and thus favoring a more proximal deposition. Despite of
these differences in protocols, the shape of the FV loops
generated in the present study appeared generally similar to
those previously reported, with a typical MCh-evoked
cumulative decrease in FEV0.1 and FVC. The FV loops
decreased gradually, with a more concave shape with
increasing MCh concentrations, reflecting an increasing
degree of airflow obstruction. The assessment of airway
responsiveness using the clinically-resembling parameters
FEV0.1 or FVC revealed functional changes in the HDM-
model of asthma studied, as well as in the LPS-ALI one.
Although in that latter model, the separation between
groups was much smaller compared to the HDM-model, as
also seen with the FOT technique. The difference in the
level of statistical significance observed between the two
measurement techniques in the LPS-ALI model could be
related to the fact that small group sizes were analyzed or,
alternatively, to the possibility that FOT and FE measure-
ments are influenced by different determinants or deter-
minant distributions [10]. In agreement with the latter
point, there was no statistical difference between the LPS-
ALI and control groups when FE results were normalized
to the 0 mg/ml (saline) challenge (data not shown). The
FEV0.1 response curves also allowed, at least in the HDM-
induced asthma model, the calculation of the provocative
MCh concentration inducing a 20 (PC20), 30 (PC30), or
40% (PC40) decrease in FEV and a classification of the
subjects’AHR response as either mild, moderate, or severe,
as performed clinically with human data [30, 31].
The addition of FE measurements to other types of lung
function evaluations (e.g. FOT, PV loops, specific volumes)
contributed, in the present study, to produce a more
complete functional characterization of four well estab-
lished respiratory disease models, all generated on the same
genetic background. This approach helped confirm disease
specific phenotypes while further assessing distinctive
changes using a number of clinically-resembling parame-
ters. The translational utility of these latter parameters to
human spirometry still remains to be established and their
interpretation is also not fully understood. However, non-
linear behaviors of the lung, such as expiratory flow limita-
tion, often play important roles in respiratory diseases and
their evaluation should be, in our view, more frequently
included in the evaluation of preclinical models as well as
extended. For example, future studies could consider, more
chronic models, different genetic backgrounds, as well as
additional lung function measurements (e.g. additional lung
volumes) or conditions under which measurements are
made (e.g. different PEEP or negative pressure).
Conclusion
In conclusion, four well established mouse models of
respiratory diseases were characterized with the object-
ive of further assessing disease-specific changes using
FE-related parameters. The results showed that lung
function defects could be detected in each disease model
by at least one FE-derived parameter under baseline or
bronchoconstricted conditions and that the changes
Devos et al. Respiratory Research  (2017) 18:123 Page 12 of 14
observed generally behaved in a similar manner as in
human patients. Routinely exploring the linear and non-
linear lung behaviors in order to produce more compre-
hensive and insightful lung function assessments in
mouse models could be key in increasing the transla-
tional utilities of preclinical studies.
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